Protagonist Therapeutics, Inc. (NASDAQ:PTGX) | WebDisclosure

Basculer en Français

10873	Companies
236403	Keywords
165301	Articles
126784	Press releases

Headlines Articles Press releases Protagonist Therapeutics, Inc.

Home
Companies
Protagonist Therapeutics, Inc.

PRESS RELEASE

published on 05/14/2024 at 22:05, 2 years 3 months ago

Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
Protagonist Therapeutics to present rusfertide Phase 2 REVIVE study data at EHA Congress in Madrid. Study shows absence of QTc prolongation with rusfertide. Details on pipeline drugs and collaborations available on company's website

Clinical Development Collaborations Protagonist Therapeutics Rusfertide EHA Congress

Accesswire

Published on 08/24/2026 at 16:00, 2 minutes ago

Critical Elements - le programme de forage estival de 10 000 mètres À rose ouest continu de livrer des résultats positifs
Published on 08/24/2026 at 15:00, 1 hour 2 minutes ago

Silver Storm Announces Upsize of Non-Brokered Private Placement to $15.0 Million
Published on 08/24/2026 at 14:30, 1 hour 32 minutes ago

AIAI Holdings Commences Discussions with Messier 42 LLC Regarding Acquisition Opportunities
Published on 08/24/2026 at 13:45, 2 hours 17 minutes ago

Amarc Announces CAD$20 Million Private Placement Financing
Published on 08/24/2026 at 13:30, 2 hours 32 minutes ago

ZTEST Electronics Inc. Announces the Grant of Stock Options to CEO and Directors

View all ACCESSWIRE

EQS Group

Published on 08/24/2026 at 15:45, 17 minutes ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN appoints Jonathan M. Pratt as Chief Executive Officer
Published on 08/24/2026 at 15:37, 25 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/24/2026 at 15:37, 25 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DNO Iraq AS (a wholly owned subsidiary of DNO ASA)
Published on 08/24/2026 at 15:36, 26 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 08/24/2026 at 15:36, 26 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 08/24/2026 at 12:25, 3 hours 37 minutes ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 17 to August 21 2026
Published on 08/24/2026 at 12:25, 3 hours 37 minutes ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 17 au 21 août 2026
Published on 08/24/2026 at 11:58, 4 hours 4 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 juillet 2026
Published on 08/24/2026 at 11:58, 4 hours 4 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of July 31, 2026
Published on 08/21/2026 at 18:33, 2 days 21 hours ago

260821 BENETEAU Transaction sur actions propres

View all LES ECHOS COMFI WIRE